Motor disturbance induced by tremorine and oxotremorine.
D000109:Acetylcholine / Q000502:physiology; D000588:Amines / Q000502:physiology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001712:Biperiden / Q000494:pharmacology; D001921:Brain / Q000503:physiopathology; D001952:Bridged-Ring Compounds / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004576:Electromyography; D004983:Ethanolamines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009046:Motor Neurons / Q000187:drug effects / Q000503:physiopathology*; D010276:Parasympatholytics / Q000494:pharmacology*; D010300:Parkinson Disease / Q000209:etiology; D010879:Piperazines / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011759:Pyrrolidines / Q000037:antagonists & inhibitors; D051381:Rats; D012018:Reflex / Q000187:drug effects; D013127:Spinal Nerves / Q000503:physiopathology*; D014202:Tremor / Q000139:chemically induced* / Q000188:drug therapy; D014203:Tremorine / Q000037:antagonists & inhibitors; D014665:Vasodilator Agents / Q000494:pharmacology
D000588:Amines; D001952:Bridged-Ring Compounds; D004983:Ethanolamines; D010276:Parasympatholytics; D010879:Piperazines; D011759:Pyrrolidines; D014665:Vasodilator Agents; D001712:Biperiden; D011343:Procaine; D004295:Dihydroxyphenylalanine; D001285:Atropine; D011433:Propranolol; D000109:Acetylcholine; D002746:Chlorpromazine; D014203:Tremorine